Brief: Infinity Pharmaceuticals Expects Net Loss For 2021 To Range From $40 Mln To $50 Mln
16/03/2021 20:14
March 16 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS REPORTS FULL YEAR 2020 FINANCIAL
RESULTS AND PROVIDES UPDATE ON EGANELISIB DEVELOPMENT
* INFINITY PHARMACEUTICALS - EXPECTS NET LOSS FOR 2021 TO
RANGE
FROM $40 MILLION TO $50 MILLION
* INFINITY PHARMACEUTICALS - EXPECTS TO END 2021 WITH CASH,
EQUIVALENTS & AVAILABLE FOR SALE SECURITIES BALANCE RANGING FROM
$70 MILLION TO $80 MILLION
Source text for Eikon: ID:nBwbyHzPNa
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX